Revive Therapeutics To Submit Updated Briefing Package in Support of Upcoming Type C Meeting Granted by FDA for Amended Protocol Agreement of Phase 3 Clinical Study for Bucillamine in the Treatment of COVID-19
Uncategorized January 12, 2023
Icanic Brands Company Inc. Announces the Appointment of Micah Anderson as Chief Executive Officer
Uncategorized September 6, 2022
Eden Empire Announces Partner to Lead Charge in Michigan Franchise Expansion
MichiganUncategorized January 27, 2022
OTC Markets Group Welcomes Mystic Holdings Inc. to OTCQX
Uncategorized January 21, 2022
Rapid Dose Therapeutics and McMaster University’s COVID-19 Vaccine Study Receives NSERC Research and Development Grant
Uncategorized December 22, 2021
Rapid Dose Therapeutics Completes Milestone One Million QuickStrip™ Units Shipped to a Single Company
Uncategorized November 24, 2021
Bloomios Shareholder Update & Growth Strategy
Uncategorized November 17, 2021
Schwazze Signs Definitive Agreement to Acquire Smoking Gun, LLC & Smoking Gun Land Company, LLC
Uncategorized November 15, 2021